Report Detail

Request for Sample of this report

Pharma & Healthcare Global mRNA Vaccines & Therapeutics Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM3129887
    • |
  • 26 September, 2024
    • |
  • Global
    • |
  • 105 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
According to our (Global Info Research) latest study, the global mRNA Vaccines & Therapeutics market size was valued at US$ 4007 million in 2023 and is forecast to a readjusted size of USD 1450 million by 2030 with a CAGR of -13.7% during review period.
Global core mRNA vaccines & therapeutics manufacturers include Moderna Therapeutics, CureVac etc. The top 3 companies hold a share about 65%. Europe is the largest market, with a share about 10%, followed by Asia Pacific and North America.
This report is a detailed and comprehensive analysis for global mRNA Vaccines & Therapeutics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global mRNA Vaccines & Therapeutics market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Doses), 2019-2030
Global mRNA Vaccines & Therapeutics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Doses), 2019-2030
Global mRNA Vaccines & Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Doses), 2019-2030
Global mRNA Vaccines & Therapeutics market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (USD/Doses), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for mRNA Vaccines & Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global mRNA Vaccines & Therapeutics market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
mRNA Vaccines & Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Infectious Disease Vaccines
Cancer Vaccines
Market segment by Application
Infectious Disease
Cancer
Major players covered
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe mRNA Vaccines & Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of mRNA Vaccines & Therapeutics, with price, sales quantity, revenue, and global market share of mRNA Vaccines & Therapeutics from 2019 to 2024.
Chapter 3, the mRNA Vaccines & Therapeutics competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the mRNA Vaccines & Therapeutics breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and mRNA Vaccines & Therapeutics market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of mRNA Vaccines & Therapeutics.
Chapter 14 and 15, to describe mRNA Vaccines & Therapeutics sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global mRNA Vaccines & Therapeutics Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Infectious Disease Vaccines
    • 1.3.3 Cancer Vaccines
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global mRNA Vaccines & Therapeutics Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Infectious Disease
    • 1.4.3 Cancer
  • 1.5 Global mRNA Vaccines & Therapeutics Market Size & Forecast
    • 1.5.1 Global mRNA Vaccines & Therapeutics Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global mRNA Vaccines & Therapeutics Sales Quantity (2019-2030)
    • 1.5.3 Global mRNA Vaccines & Therapeutics Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Moderna Therapeutics
    • 2.1.1 Moderna Therapeutics Details
    • 2.1.2 Moderna Therapeutics Major Business
    • 2.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Product and Services
    • 2.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Moderna Therapeutics Recent Developments/Updates
  • 2.2 CureVac
    • 2.2.1 CureVac Details
    • 2.2.2 CureVac Major Business
    • 2.2.3 CureVac mRNA Vaccines & Therapeutics Product and Services
    • 2.2.4 CureVac mRNA Vaccines & Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 CureVac Recent Developments/Updates
  • 2.3 Translate Bio
    • 2.3.1 Translate Bio Details
    • 2.3.2 Translate Bio Major Business
    • 2.3.3 Translate Bio mRNA Vaccines & Therapeutics Product and Services
    • 2.3.4 Translate Bio mRNA Vaccines & Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Translate Bio Recent Developments/Updates
  • 2.4 BioNTech
    • 2.4.1 BioNTech Details
    • 2.4.2 BioNTech Major Business
    • 2.4.3 BioNTech mRNA Vaccines & Therapeutics Product and Services
    • 2.4.4 BioNTech mRNA Vaccines & Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 BioNTech Recent Developments/Updates
  • 2.5 Sangamo Therapeutics
    • 2.5.1 Sangamo Therapeutics Details
    • 2.5.2 Sangamo Therapeutics Major Business
    • 2.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product and Services
    • 2.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Sangamo Therapeutics Recent Developments/Updates
  • 2.6 Argos Therapeutics
    • 2.6.1 Argos Therapeutics Details
    • 2.6.2 Argos Therapeutics Major Business
    • 2.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Product and Services
    • 2.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Argos Therapeutics Recent Developments/Updates
  • 2.7 In-Cell-Art
    • 2.7.1 In-Cell-Art Details
    • 2.7.2 In-Cell-Art Major Business
    • 2.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Product and Services
    • 2.7.4 In-Cell-Art mRNA Vaccines & Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 In-Cell-Art Recent Developments/Updates
  • 2.8 eTheRNA
    • 2.8.1 eTheRNA Details
    • 2.8.2 eTheRNA Major Business
    • 2.8.3 eTheRNA mRNA Vaccines & Therapeutics Product and Services
    • 2.8.4 eTheRNA mRNA Vaccines & Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 eTheRNA Recent Developments/Updates
  • 2.9 Ethris
    • 2.9.1 Ethris Details
    • 2.9.2 Ethris Major Business
    • 2.9.3 Ethris mRNA Vaccines & Therapeutics Product and Services
    • 2.9.4 Ethris mRNA Vaccines & Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Ethris Recent Developments/Updates
  • 2.10 Tiba Biotechnology
    • 2.10.1 Tiba Biotechnology Details
    • 2.10.2 Tiba Biotechnology Major Business
    • 2.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Product and Services
    • 2.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Tiba Biotechnology Recent Developments/Updates

3 Competitive Environment: mRNA Vaccines & Therapeutics by Manufacturer

  • 3.1 Global mRNA Vaccines & Therapeutics Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global mRNA Vaccines & Therapeutics Revenue by Manufacturer (2019-2024)
  • 3.3 Global mRNA Vaccines & Therapeutics Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of mRNA Vaccines & Therapeutics by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2023
    • 3.4.3 Top 6 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2023
  • 3.5 mRNA Vaccines & Therapeutics Market: Overall Company Footprint Analysis
    • 3.5.1 mRNA Vaccines & Therapeutics Market: Region Footprint
    • 3.5.2 mRNA Vaccines & Therapeutics Market: Company Product Type Footprint
    • 3.5.3 mRNA Vaccines & Therapeutics Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global mRNA Vaccines & Therapeutics Market Size by Region
    • 4.1.1 Global mRNA Vaccines & Therapeutics Sales Quantity by Region (2019-2030)
    • 4.1.2 Global mRNA Vaccines & Therapeutics Consumption Value by Region (2019-2030)
    • 4.1.3 Global mRNA Vaccines & Therapeutics Average Price by Region (2019-2030)
  • 4.2 North America mRNA Vaccines & Therapeutics Consumption Value (2019-2030)
  • 4.3 Europe mRNA Vaccines & Therapeutics Consumption Value (2019-2030)
  • 4.4 Asia-Pacific mRNA Vaccines & Therapeutics Consumption Value (2019-2030)
  • 4.5 South America mRNA Vaccines & Therapeutics Consumption Value (2019-2030)
  • 4.6 Middle East & Africa mRNA Vaccines & Therapeutics Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global mRNA Vaccines & Therapeutics Sales Quantity by Type (2019-2030)
  • 5.2 Global mRNA Vaccines & Therapeutics Consumption Value by Type (2019-2030)
  • 5.3 Global mRNA Vaccines & Therapeutics Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global mRNA Vaccines & Therapeutics Sales Quantity by Application (2019-2030)
  • 6.2 Global mRNA Vaccines & Therapeutics Consumption Value by Application (2019-2030)
  • 6.3 Global mRNA Vaccines & Therapeutics Average Price by Application (2019-2030)

7 North America

  • 7.1 North America mRNA Vaccines & Therapeutics Sales Quantity by Type (2019-2030)
  • 7.2 North America mRNA Vaccines & Therapeutics Sales Quantity by Application (2019-2030)
  • 7.3 North America mRNA Vaccines & Therapeutics Market Size by Country
    • 7.3.1 North America mRNA Vaccines & Therapeutics Sales Quantity by Country (2019-2030)
    • 7.3.2 North America mRNA Vaccines & Therapeutics Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe mRNA Vaccines & Therapeutics Sales Quantity by Type (2019-2030)
  • 8.2 Europe mRNA Vaccines & Therapeutics Sales Quantity by Application (2019-2030)
  • 8.3 Europe mRNA Vaccines & Therapeutics Market Size by Country
    • 8.3.1 Europe mRNA Vaccines & Therapeutics Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe mRNA Vaccines & Therapeutics Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific mRNA Vaccines & Therapeutics Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific mRNA Vaccines & Therapeutics Market Size by Region
    • 9.3.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific mRNA Vaccines & Therapeutics Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America mRNA Vaccines & Therapeutics Sales Quantity by Type (2019-2030)
  • 10.2 South America mRNA Vaccines & Therapeutics Sales Quantity by Application (2019-2030)
  • 10.3 South America mRNA Vaccines & Therapeutics Market Size by Country
    • 10.3.1 South America mRNA Vaccines & Therapeutics Sales Quantity by Country (2019-2030)
    • 10.3.2 South America mRNA Vaccines & Therapeutics Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa mRNA Vaccines & Therapeutics Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa mRNA Vaccines & Therapeutics Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa mRNA Vaccines & Therapeutics Market Size by Country
    • 11.3.1 Middle East & Africa mRNA Vaccines & Therapeutics Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa mRNA Vaccines & Therapeutics Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 mRNA Vaccines & Therapeutics Market Drivers
  • 12.2 mRNA Vaccines & Therapeutics Market Restraints
  • 12.3 mRNA Vaccines & Therapeutics Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of mRNA Vaccines & Therapeutics and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of mRNA Vaccines & Therapeutics
  • 13.3 mRNA Vaccines & Therapeutics Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 mRNA Vaccines & Therapeutics Typical Distributors
  • 14.3 mRNA Vaccines & Therapeutics Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on mRNA Vaccines & Therapeutics. Industry analysis & Market Report on mRNA Vaccines & Therapeutics is a syndicated market report, published as Global mRNA Vaccines & Therapeutics Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of mRNA Vaccines & Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo